VULVAR CANCER
Clinical trials for VULVAR CANCER explained in plain language.
Never miss a new study
Get alerted when new VULVAR CANCER trials appear
Sign up with your email to follow new studies for VULVAR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise against Hard-to-Treat HPV cancers
Disease control OngoingThis study tests whether a mix of three immunotherapy drugs can shrink tumors in people with advanced HPV-related cancers, such as cervical, anal, and throat cancers. About 51 adults with cancers that have spread or not responded to standard treatments will receive the drugs for …
Matched conditions: VULVAR CANCER
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 22, 2026 12:06 UTC
-
New Triple-Drug attack shows promise against tough cancers
Disease control OngoingThis study tests a combination of three drugs (entinostat, PDS01ADC, and bintrafusp alfa) in adults with advanced cancers linked to HPV or certain colon cancers that haven't responded to standard treatments. The goal is to find a safe dose and see if the treatment can shrink tumo…
Matched conditions: VULVAR CANCER
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 17, 2026 12:09 UTC
-
New combo therapy shows promise for Hard-to-Treat vulvar cancer
Disease control OngoingThis study tests whether combining standard chemotherapy (cisplatin) and radiation with an immunotherapy drug (pembrolizumab) can shrink or control advanced vulvar cancer that cannot be removed by surgery. The trial includes 24 adults with unresectable, recurrent, or metastatic v…
Matched conditions: VULVAR CANCER
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New hope for advanced cancers: immunotherapy drug shows promise
Disease control OngoingThis study tests the drug pembrolizumab in about 1,600 people with various advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug can shrink or control the tumors. Participants receive pembrolizumab and are monitored for tumor respons…
Matched conditions: VULVAR CANCER
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New imaging technique could improve lymph node detection in vulvar cancer
Diagnosis OngoingThis study tests a newer imaging method (ICG-NIR) against the standard one (lymphoscintigraphy) to see which better finds sentinel lymph nodes in early-stage vulvar cancer. About 22 adults with small tumors will take part. The goal is to improve accuracy during surgery.
Matched conditions: VULVAR CANCER
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 18, 2026 11:50 UTC
-
Can a Mid-Treatment scan make radiation smarter?
Knowledge-focused OngoingThis study is testing whether doing a special PET scan during radiation treatment can help doctors adjust the plan to better target tumors and spare healthy tissue. It involves 90 adults with cervical, vulvar, esophageal, or anal cancer. The goal is to see if this approach improv…
Matched conditions: VULVAR CANCER
Phase: PHASE2 • Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 23, 2026 20:32 UTC
-
Can community navigation cut cancer delays? botswana trial aims to find out
Knowledge-focused OngoingThis study tests a program called Potlako+ that combines community education, support for healthcare providers, and patient navigation to help people with cancer symptoms get diagnosed and treated faster. About 874 participants in Botswana will be split into two groups: one recei…
Matched conditions: VULVAR CANCER
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:57 UTC
-
Blood test may help cancer patients avoid nerve damage from chemo
Knowledge-focused TerminatedThis pilot study aims to see if doctors can consistently measure paclitaxel levels in the blood of cancer patients receiving the drug. The goal is to eventually adjust doses to give enough chemo to fight cancer while reducing the common side effect of nerve damage. The study invo…
Matched conditions: VULVAR CANCER
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:57 UTC